Association of nonpharmaceutical interventions during the COVID-19 pandemic with invasive pneumococcal disease, pneumococcal carriage, and respiratory viral …

A Rybak, C Levy, F Angoulvant, A Auvrignon… - JAMA network …, 2022 - jamanetwork.com
Importance An association between pneumococcal nasopharyngeal carriage and invasive
pneumococcal disease (IPD) has been previously established. However, it is unclear …

Prevention of pneumococcal infections in childhood: two decades of progress

EB Walter, MJ Smith - Current Opinion in Pediatrics, 2022 - journals.lww.com
Despite proven safety and efficacy, childhood vaccination programs in some countries do
not include PCVs, resulting in the majority of global deaths attributable to pneumococcus …

Impact of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease and pneumonia in The Gambia: 10 years of population-based …

GA Mackenzie, PC Hill, DJ Jeffries… - The Lancet Infectious …, 2021 - thelancet.com
Summary Background The Gambia introduced seven-valent pneumococcal conjugate
vaccine (PCV7) in August 2009, followed by PCV13 in May, 2011, using a schedule of three …

[PDF][PDF] Diversity of serotype replacement after pneumococcal conjugate vaccine implementation in Europe

C Levy, N Ouldali, L Caeymaex, F Angoulvant… - The Journal of …, 2019 - Elsevier
Streptococcus pneumoniae is the leading cause of bacterial infections in children, including
meningitis, bacteremia, bacteremic pneumonia, empyema, and mucosal infections such as …

Progress in mucosal immunization for protection against pneumococcal pneumonia

VM Gonçalves, K Kaneko, C Solórzano… - Expert Review of …, 2019 - Taylor & Francis
Introduction: Lower respiratory tract infections are the fourth cause of death worldwide and
pneumococcus is the leading cause of pneumonia. Nonetheless, existing pneumococcal …

Diagnostic accuracy of routinely available biomarkers to predict bacteremia in children with community-acquired pneumonia: A Secondary analysis of the GPIP/ACTIV …

D Dudognon, C Levy, M Chalumeau, S Biscardi… - Frontiers in …, 2021 - frontiersin.org
Objective (s): Blood cultures (BC), when performed in children seen in the emergency
department with community-acquired pneumonia (CAP), are most of the time sterile. We …

Variation in management and outcomes of children with complicated pneumonia

CJ Gross, JJ Porter, SC Lipsett… - Hospital …, 2021 - publications.aap.org
OBJECTIVES: To assess the characteristics of children hospitalized with complicated
pneumonia at US children's hospitals and compare these characteristics with those of …

Pleural tap-guided antimicrobial treatment for pneumonia with parapneumonic effusion or pleural empyema in children: a single-center cohort study

PM Meyer Sauteur, A Burkhard, U Moehrlen… - Journal of clinical …, 2019 - mdpi.com
Parapneumonic effusion or pleural empyema (PPE/PE) is a frequent complication of
community-acquired pneumonia (CAP) in children. Different management approaches exist …

Incidence of acute chest syndrome in children with sickle cell disease following implementation of the 13-valent pneumococcal conjugate vaccine in France

Z Assad, M Michel, Z Valtuille, A Lazzati… - JAMA Network …, 2022 - jamanetwork.com
Importance Acute chest syndrome (ACS) is one of the leading acute severe complications of
sickle-cell disease (SCD). AlthoughStreptococcus pneumoniae (S pneumoniae) is highly …

Ventilator-associated pneumonia is linked to a worse prognosis than community-acquired pneumonia in children

M Hernandez-Garcia, M Girona-Alarcon… - PLoS …, 2022 - journals.plos.org
Background Around 12–20% of patients with community-acquired pneumonia (CAP) require
critical care. Ventilator-associated pneumonia (VAP) is the second cause of nosocomial …